# Post-Exposure Prophylaxis in Health Care Workers

> **NCT01234116** · PHASE4 · COMPLETED · sponsor: **Henry Ford Health System** · enrollment: 16 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DRUG:** emtricitabine/tenofovir disoproxil fumarate

## Key facts

- **NCT ID:** NCT01234116
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01234116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01234116, "Post-Exposure Prophylaxis in Health Care Workers". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01234116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*